Pharmacological treatment of neuropathic pain in primary care;Traitement pharmacologique des douleurs neuropathiques en soins de premier recours

Revue du Praticien

Volumn 63, Issue 6, 2013, Pages 795-802

  Attal, Nadine ^a,b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DULOXETINE; GABAPENTIN; LIDOCAINE; OPIATE; PREGABALIN; TRAMADOL;

MONOTHERAPY; NEUROPATHIC PAIN; PRIMARY MEDICAL CARE; REVIEW;

AGE OF ONSET; ALGORITHMS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; NEURALGIA; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE;

EID: 84880545819     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992;2:285-9.
2. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain : redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-5
3. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;136:380-7.
4. Attal N, Lanteri-Minet M, Laurent B, Fermanian J, Bouhassira D. The specific disease burden of neuropathic pain : results of a French nationwide survey. Pain 2011;152:2836-43.
5. Attal N, Cruccu G, Baron R. EFNS guidelines on pharmacological treatment of neuropathic pain. 2009 revision. Eur J Neurol 2010;17:1113-e88.
6. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010;9:807-19.
7. Bouhassira D, Attal N. Les douleurs neuropathiques. Paris : Arnette, Doin, 2011.
8. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005,352:1324-34.
9. Gilron I, Baley JM, Tu D, Holdem DR, Jackson AC, Houlden RL. Nortritpyline and gabapentin, alone and in combination for neuropathic pain a double-blind, randomised controlled crossover trial. Lancet 2009;374.1252-61.
10. Tesfaye S http://www.ncbi.nim.nih.gov/pubmed?term= Tesfaye%20S%5BAuthor%5D&cauthor=true&cauthor-uid=23732189, Wilheim S 〈http://www.ncbi.nim.nih.gov/pubmed?term=Wilheim%20S%5BAuthor%5D& cauthor=true&cauthor-uid=2373 2189, Lledo A http://www.ncbi.nim.nih.gov/ pubmed?term=Lledo%20A%5BAuthor%5D&cauthor=true&cauthor-uid=237321 89, et al. Duloxetine and pregabalin: High-dose monotherapy or their combination? The COMBO-DN study - a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain http://www.ncbi.nim.nih.gov/pubmed/?term=Duloxetin+and+pregabalin%3A+hidh- dos+monotherapy 2013. doi: 101016/j.pain.2013.05.043. [Epub ahead of print]
11. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence based recommendations. Pain 2007;132:237-51.
12. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573-81.
13. Martinez V, Altal N, Bouhassira D, Lanteri-Minet D. Douleurs neuropathiques: diagnostic, évaluation, traitement. Recommandations de la SFETD. Neurologies 2010; http://www.sfetd-douleur.org/
14. Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurology 2009;7:1106-2.
15. Simpson DM, Brown S, Tobias J. NGX-4010 C107 Study Group. Controlled trial of high-concentration capsaicin patch for treatment of painful HW neuropathy. Neurology 2008;70:2305-13.